MET and breast cancer: In addition, Baccelli et al. (2013) characterized the metastasis-initiating subpopulation of breast cancer CTCs as positive for EpCAM, tyrosine-protein kinase Met (cMet), CD44, and CD47 (Baccelli et al., 2013).